Semaglutide Patent Expiry: Cheaper Weight Loss Drugs, Prices Drop & Availability Boost
Published on: March 21, 2026, 11:44 a.m. | Source: Times Now
Semaglutide’s patent expiry could transform weight loss drug access, with cheaper generics and up to 50 brands launching in India. Prices may drop significantly, improving affordability and availability. Widely used for obesity and diabetes, the drug’s demand has surged globally. Experts say increased supply could ease shortages, but patients should use it under medical supervision. , Health, Times Now
